Org OD 14 and the endometrium
article
OA: closed
CC0
⤵ 14 in-corpus citations
AI-generated summary
This paper investigates the effects of Org OD 14 on the endometrium.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Long-term therapy with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14; tibolone, Livial) has no influence on the endometrium in post-menopausal women. This was concluded from endometrial biopsies taken from 39 post-menopausal women treated with 2.5 mg/day for periods of from 3 months to 5 years 11 months at three centres. These results accord with the data published so far on 129 women who have been treated for up to 2 years. A review of the data relating to a total of 168 patients treated with Org OD 14 is presented. The endometrial pattern observed at the start of therapy showed no change during treatment in 90% of patients. In 15 cases slight proliferation was apparent after treatment, this being a similar pattern to that seen in the initial days of a normal cycle. In a considerable number of patients no tissue could be obtained, indicating an atrophic pattern. The picture following Org OD 14 therapy was the same as that observed in untreated normal post-menopausal women.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- W45007598 via openalex
- W1976445188 via openalex
- W1984955008 via openalex
- W2018671276 via openalex
- W2028752503 via openalex
- W2030908961 via openalex
- W2048182846 via openalex
- W2053127900 via openalex
- W2060066965 via openalex
- W2081496304 via openalex
- W2086684542 via openalex
- W2087306228 via openalex
- W2127857303 via openalex
- W2150150420 via openalex
- W2415486290 via openalex
Cited by (12)
- De novo postmenopausal endometriosis during tibolone treatment: a case report and review of the literature 2007
- Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen 2006
- Effects of tibolone on the endometrium 2001
- Long term effects of tibolone on the genital tract in postmenopausal women 1999
- Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis 1997
- Microscopic evaluation of the effect of hormone replacement therapy on the endometrium in women who bleed 1997
- Failure of tibolone to control hypoestrogenic symptoms in premenopausal women undergoing hysterectomy and bilateral salpingoophorectomy 1997
- Immunohistochemical and hysteroscopic assessment of postmenopausal women with uterine bleeding whilst taking Tibolone 1996
- Immunohistochemical and hysteroscopic assessment of postmenopausal women with uterine bleeding whilst taking Tibolone 1996
- The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl) 1996
- Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125 1994
- New drugs and new uses for existing drugs which act on the uterus: Gynaecology 1992
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-08-21T06:37:11.537704+00:00
License: CC0
· commercial use OK